Effects of Low-frequency Electrical Stimulation in Patients With Advanced HF
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to verify the effects of low frequency functional electrical stimulation in heart failure patients hospitalized for treatment of the syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started May 2009
Longer than P75 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 9, 2013
CompletedFirst Posted
Study publicly available on registry
June 25, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedDecember 3, 2015
April 1, 2013
5.3 years
April 9, 2013
December 2, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Functional assessment
To assess the effects of the functional electrical stimulation in patients with advanced heart failure.
10 days
Secondary Outcomes (2)
Peripheral function
10 days
Peripheral muscle strength
10 days
Study Arms (2)
Functional Electrical Stimulation
EXPERIMENTALFunctional Electrical Stimulation for 10 days
Control Electrical Stimulation
PLACEBO COMPARATORControl Electrical Stimulation for 10 days
Interventions
Functional electrical stimulation for 10 days
Placebo electrical stimulation for 10 days
Eligibility Criteria
You may qualify if:
- Patients with advanced heart failure,
- Class Functional IV, according to the criteria of New York Heart Association (NYHA),
- Aged over 18 years,
- Etiology hypertensive, ischemic, idiopathic or chagas disease,
- Left ventricular ejection fraction ≤ 30%.
You may not qualify if:
- Patients with hypertension lung disease and oxygen-dependent,
- Neurological and neuromuscular disease that presenting paresthesia or plegia of the lower limbs,
- Insulin-dependent diabetes mellitus (type I),
- Peripheral arterial occlusive disease,
- Peripheral neuropathy,
- Use of pacemaker or implantable cardiodefibrillator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto do Coração - HC/FMUSP
São Paulo, São Paulo, 05403-900, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD student
Study Record Dates
First Submitted
April 9, 2013
First Posted
June 25, 2013
Study Start
May 1, 2009
Primary Completion
August 1, 2014
Study Completion
December 1, 2014
Last Updated
December 3, 2015
Record last verified: 2013-04